SR 3775

Drug Profile

SR 3775

Alternative Names: Ganciclovir cyclic phosphonate

Latest Information Update: 10 Sep 1998

Price : $50

At a glance

  • Originator SRI International
  • Class Antivirals; Small molecules
  • Mechanism of Action DNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cytomegalovirus infections

Most Recent Events

  • 10 Sep 1998 No-Development-Reported for Cytomegalovirus infections in USA (Unknown route)
  • 26 Aug 1996 New profile
  • 26 Aug 1996 Preclinical development for Cytomegalovirus infections in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top